Evidence map›Paper›PMID 27408512›Full record

ArticleJournal of orthopaedics2016

Is there a treatment protocol in which platelet-rich plasma is effective?

Ibrahim Yilmaz, Semih Akkaya, Mehmet Isyar, Ahmet Güray Batmaz, Olcay Guler, Kadir Oznam, Akin Ugras, Mahir Mahiroğullari

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of orthopaedics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ibrahim YilmazRepublic of Turkey Ministry of Health, State Hospital, Department of Pharmacovigilance, Materiovigilance and Rational Use of Drugs, 59100 Tekirdag, Turkey.
Semih AkkayaPamukkale University School of Medicine, Department of Orthopaedic and Traumatology, 20070 Denizli, Turkey.
Mehmet IsyarCentral Hospital Health Group, Department of Orthopaedic and Traumatology, 34742 Istanbul, Turkey.
Ahmet Güray BatmazIstanbul Medipol University School of Medicine, Department of Orthopaedic and Traumatology, 34214 Istanbul, Turkey.
Olcay GulerIstanbul Medipol University School of Medicine, Department of Orthopaedic and Traumatology, 34214 Istanbul, Turkey.
Kadir OznamIstanbul Medipol University School of Medicine, Department of Orthopaedic and Traumatology, 34214 Istanbul, Turkey.
Akin UgrasIstanbul Medipol University School of Medicine, Department of Orthopaedic and Traumatology, 34214 Istanbul, Turkey.
Mahir MahiroğullariMemorial Health Group, Department of Orthopaedic and Traumatology, 34384 Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimWe aimed to reveal whether there are prospective suggestions for effective and standard platelet-rich plasma applications.

methodsWe searched for clinical trials and traced all the references of incorporated documents.

resultsIn literature, there was no study indicating which disease is treated by which mechanism of action, how much dose and content are prepared and applied, when the treatment is applied and how many cures are applied.

conclusionGuides introducing which concentrations of PRP are used for which diseases are to be prepared immediately by a committee which is comprised of primarily orthopedists, clinical pharmacologists and toxicologists.

Indexed as

EpicondylitisPain following arthroplastyPlatelet-rich plasmaProximal hamstringRotator cuff damageTendinopathy

Identifiers

PMID27408512
PMCPMC4933039

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.